Group by: Item Type | No Grouping
Number of items: 6.

Article

Alabas, O, Mason, KJ ORCID: https://orcid.org/0000-0002-5419-0669, Yiu, Z, Warren, R, Lunt, M, Smith, C and Griffiths, C (2022) Real-world effectiveness and persistence of methotrexate versus adalimumab: A comparative study from the British association of dermatologists biologics and immunomodulators register (BADBIR). Pharmacoepidemiology and Drug Safety, 31 (S2). 490 - 490.

Warren, RB, Marsden, A, Tomenson, B, Mason, KJ ORCID: https://orcid.org/0000-0002-5419-0669, Soliman, MM, Burden, AD, Reynolds, NJ, Stocken, D, Emsley, R, Griffiths, CEM, Smith, C, Consortium, PSORT and Study Group, BADBIR (2018) Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study. British Journal of Dermatology, 180 (5). 1069 - 1076.

Kishore, A, Vail, A, Bray, B, Chamorro, A, Di Napoli, M, Kalra, L, Langhorne, P, Montaner, J, Roffe, C ORCID: https://orcid.org/0000-0002-5259-6649, Rudd, A, Tyrrell, A, Van de Beek, D, Woodhead, M, Meisel, A and Smith, C (2016) Clinical risk scores for predicting stroke-associated pneumonia: A systematic review. European Stroke Journal, 1 (2). 76 - 84.

Cohen, DL, Roffe, C, Beavan, J, Blackett, B, Fairfield, CA, Hamdy, S, Havard, D, McFarlane, M, McLaughlin, C, Randall, M, Robson, K, Scutt, P, Smith, C, Smithard, D, Sprigg, N, Warusevitane, A, Watkins, C, Woodhouse, L and Bath, PM (2016) Post-stroke dysphagia: A review and design considerations for future trials. International Journal of Stroke, 11 (4). 399 - 411.

Gándara, E, Warusevitane, A, Karunatilake, D, Sim, J ORCID: https://orcid.org/0000-0002-1816-1676, Smith, C and Roffe, C (2016) Early Diagnosis of Pneumonia in Severe Stroke: Clinical Features and the Diagnostic Role of C-Reactive Protein. PLoS One, 11 (3). 0150269-?.

Conference or Workshop Item

Roffe, C ORCID: https://orcid.org/0000-0002-5259-6649, Bath, P, Warusevitane, A, Smith, C, Dixit, A, Sprigg, N, Helliwell, B, Phillips, N, Sim, J, Jowett, S and Ogollah, R (2021) THE METOCLOPRAMIDE FOR AVOIDING PNEUMONIA AFTER STROKE (MAPS-2) TRIAL: A SINGLE-BLIND RCT OF METOCLOPRAMIDE FOR THE PREVENTION OF PNEUMONIA IN PATIENTS WITH DYSPHAGIA AFTER STROKE. In: UK Stroke Forum 2021, 30 Nov - 02 Dec 2021, Virtual.

This list was generated on Tue Oct 31 06:40:45 2023 UTC.